Associations between second-generation antipsychotics and metabolic outcomes in patients with schizophrenia and metabolic abnormalities. [PDF]
Liao Z +28 more
europepmc +1 more source
Metabolic and Endocrine ADRs of Atypical Antipsychotics (AAPs) in Paediatric Patients with Autism Spectrum Disorder (ASD): A Review of Prevalence, Risk Factors, and Implications for Clinical Monitoring. [PDF]
Aljead M, Qashta A, Jalal Z, Jones AM.
europepmc +1 more source
Impact of CYP3A4 functional variability on ziprasidone metabolism. [PDF]
Zhou Q +7 more
europepmc +1 more source
Efficacy and Safety of Ziprasidone Injection vs Haloperidol Injection for Agitation in Patients with Acute Schizophrenia. [PDF]
Qi S +8 more
europepmc +1 more source
Special Issue "Redox Homeostasis and Oxidative Stress in Human Metabolism and Disease: 2nd Edition". [PDF]
Nuszkiewicz J, Woźniak A.
europepmc +1 more source
Post-lanosterol inhibition profile based classification of commonly used prescription medications. [PDF]
Tallman KA +4 more
europepmc +1 more source
The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 2:Review, grading of the evidence and a precise algorithm [PDF]
Aberg-Wistedt +239 more
core +1 more source
Antipsychotic Misuse: A Silent but Growing Public Health Hazard. [PDF]
Bhardwaj S +4 more
europepmc +1 more source
Efficacy and tolerability of pharmacological interventions for schizophrenia non-responsive to prior treatment: a systematic review and network meta-analysis. [PDF]
Samara M +10 more
europepmc +1 more source

